6621.TWO
Price:
$12.05
Market Cap:
$427.79M
UniPharma Co., Ltd. engages in the distribution of pharmaceutical drugs, medical devices, and diagnostic tests in Taiwan. The company provides diagnostic tests in areas of oncology, gynecology, orthopedics, neurology, anesthesiology, and cardiology. It offers Adept reduction solution; bain, esmolol HCI, and naloxone anesthesia injections; Elisa DR-70 test for in-vitro diagnostics of tumors; and fomeject antidote injection, as well as drug development, research and development, clinical trials, marketing, and other business services. It serves medical centers, regional and area hospitals, and clinics. UniPharma Co., Ltd. was incorporated in 1998 and is based in Taipei, Taiwan.
Industry
Drug Manufacturers - Specialty & Generic
IPO Date
2017-08-18
Stock Exchange
TWO
Ticker
6621.TWO
According to UniPharma Co., Ltd.’s latest financial reports and current stock price. The company's current ROE is -14.49%. This represents a change of 149.06% compared to the average of -5.82% of the last 4 quarters.
The mean historical ROE of UniPharma Co., Ltd. over the last ten years is -10.61%. The current -14.49% ROE has changed 36.56% with respect to the historical average. Over the past ten years (40 quarters), 6621.TWO's ROE was at its highest in in the June 2019 quarter at 0%. The ROE was at its lowest in in the December 2021 quarter at -12.50%.
Average
-10.61%
Median
-7.85%
Minimum
-25.00%
Maximum
-2.13%
Discovering the peaks and valleys of UniPharma Co., Ltd. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 228.19%
Maximum Annual ROE = -2.13%
Minimum Annual Increase = -91.50%
Minimum Annual ROE = -25.00%
| Year | ROE | Change |
|---|---|---|
| 2024 | -8.72% | 24.94% |
| 2023 | -6.98% | 228.19% |
| 2022 | -2.13% | -91.50% |
| 2021 | -25.00% | 71.20% |
| 2020 | -14.61% | 133.97% |
The current ROE of UniPharma Co., Ltd. (6621.TWO) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-5.94%
5-year avg
-11.49%
10-year avg
-10.61%
UniPharma Co., Ltd.’s ROE is greater than DuoGenic StemCells corporation (-248.08%), greater than EPS Bio Technology Corp. (-4.75%), greater than Pharmigene, Inc. (-22.90%), less than Welgene Biotech Co.,Ltd. (0.80%), greater than Taiwan Advanced Nanotech Inc. (-21.37%), greater than Sunder Biomedical Tech. Co., Ltd. (-1.35%), less than iXensor Co., Ltd. (1.46%), less than Bioray Biotech Co., Ltd (7.09%), less than A-SPINE Asia Co., Ltd. (3.71%), greater than Health & Life Co., Ltd. (-3.67%),
| Company | ROE | Market cap |
|---|---|---|
| -248.08% | $679.06M | |
| -4.75% | $404.60M | |
| -22.90% | $524.90M | |
| 0.80% | $438.12M | |
| -21.37% | $484.03M | |
| -1.35% | $514.20M | |
| 1.46% | $256.33M | |
| 7.09% | $606.50M | |
| 3.71% | $531.43M | |
| -3.67% | $530.97M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like UniPharma Co., Ltd. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like UniPharma Co., Ltd. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the ROE?
How can you use the ROE?
What is UniPharma Co., Ltd.'s ROE?
How is the ROE calculated for UniPharma Co., Ltd. (6621.TWO)?
What is the highest ROE for UniPharma Co., Ltd. (6621.TWO)?
What is the 3-year average ROE for UniPharma Co., Ltd. (6621.TWO)?
What is the 5-year average ROE for UniPharma Co., Ltd. (6621.TWO)?
How does the current ROE for UniPharma Co., Ltd. (6621.TWO) compare to its historical average?